Results 91 to 100 of about 6,216 (159)

Imaging Properties and Tumor Targeting of ⁶⁸Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients. [PDF]

Biomedicines, 2022
Gruber L, Decristoforo C, Uprimny C, Hohenberger P, Schoenberg SO, Orlandi F, Mariani MF, Manzl C, Kasseroler MT, Tilg H, Zelger B, Jaschke WR, Virgolini IJ.   +12 more
europepmc   +1 more source

Gastrin-Releasing Peptide Receptor Antagonist [⁶⁸Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer. [PDF]

Cancers (Basel), 2021
Michalski K, Kemna L, Asberger J, Grosu AL, Meyer PT, Ruf J, Sprave T.   +6 more
europepmc   +1 more source

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? [PDF]

Front Oncol, 2021
Faviana P, Boldrini L, Erba PA, Di Stefano I, Manassero F, Bartoletti R, Galli L, Gentile C, Bardi M.   +8 more
europepmc   +1 more source

Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in ¹⁷⁷Lu-RM2 Results in ¹⁷⁷Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability. [PDF]

J Nucl Med, 2022
Günther T, Deiser S, Felber V, Beck R, Wester HJ.   +4 more
europepmc   +1 more source

⁶⁸Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [⁶⁸Ga]Ga-RM2. [PDF]

Pharmaceutics, 2021
Chastel A, Vimont D, Claverol S, Zerna M, Bodin S, Berndt M, Chaignepain S, Hindié E, Morgat C.   +8 more
europepmc   +1 more source

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics. [PDF]

Front Oncol
Yang Y, Fu J, Tang S, Liu T, Hu H, Guo H, Wen L, Yang Y, Liu C, Yi G, Yu L, Zhou H.   +11 more
europepmc   +1 more source

Diagnostic performance of gastrin-releasing peptide receptor-targeted positron-emission tomography in biochemically recurrent prostate cancer-a systematic review and meta-analysis. [PDF]

Quant Imaging Med Surg
Huang H, Huang Y, Xie Z, Tian R, Shen G.
europepmc   +1 more source

Phase 1 Study of [¹⁷⁷Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results. [PDF]

J Nucl Med
Mittra ES, Solnes LB, van der Veldt AAM, Wong J, Aloj L, Heinrich MC, Chen CT, Rowe SP, Brabander T, Pacey S, Aimone P, Pathak D, Blumenstein L, Liu Y, Iagaru A.   +14 more
europepmc   +1 more source

Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus. [PDF]

ACS Pharmacol Transl Sci
Kumar N, Bilinska A, Menéndez E, Läppchen T, Kanellopoulos P, Orlova A, Rösch F, Rominger A, Gourni E.   +8 more
europepmc   +1 more source

The Neurokinin-1 Receptor is Expressed with Gastrin-Releasing Peptide Receptor in Spinal Interneurons and Modulates Itch. [PDF]

J Neurosci, 2020
Sheahan TD, Warwick CA, Fanien LG, Ross SE.   +3 more
europepmc   +1 more source